Error message

Deprecated function: Using ${var} in strings is deprecated, use {$var} instead in include_once() (line 1442 of includes/bootstrap.inc).
Deprecated function: Using ${var} in strings is deprecated, use {$var} instead in include_once() (line 1442 of includes/bootstrap.inc).
Deprecated function: Optional parameter $type declared before required parameter $nid is implicitly treated as a required parameter in include_once() (line 1442 of includes/bootstrap.inc).

G 0001/92 (Availability to the public) of 18.12.1992

European Case Law Identifier:

ECLI:EP:BA:1992:G000192.19921218

Date of decision:

18 December 1992

Case number:

G 0001/92

Application number:

-

IPC class:

-

Language of proceedings:

EN

Distribution:

A

Download and more information:

Decision text in EN (PDF, 269Â KB)
-
Bibliographic information is available in:	EN
Versions:	OJ \| Published

Title of application:

-

Applicant name:

-

Opponent name:

-

Board:

EBA

Headnote:

1. The chemical composition of a product is state of the art when the product as such is available to the public and can be analysed and reproduced by the skilled person, irrespective of whether or not particular reasons can be identified for analysing the composition.
2. The same principle applies mutatis mutandis to any other product.

Relevant legal provisions:

European Patent Convention 1973 Art 54
European Patent Convention 1973 Art 112(1)(a)

Keywords:

Novelty
State of the art
Availability
Composition of the product
Public prior use

Catchwords:

-

Cited decisions:

T 0406/86
T 0093/89

Citing decisions:

T 0089/91
T 0627/91
T 0083/92
T 0223/92
T 0267/92
T 0327/92
T 0472/92
T 0952/92
T 0210/93
T 0268/93
T 0443/93
T 0886/93
T 0951/93
T 0977/93
T 0097/94
T 0301/94
T 0667/94
T 0098/95
T 0144/95
T 0277/95
T 0721/95
T 0080/96
T 0165/96
T 0459/96
T 0461/96
T 0494/96
T 0571/96
T 0375/97
T 0622/97
T 0633/97
T 1046/97
T 1054/97
T 0102/98
T 0219/98
T 0226/98
T 0861/98
T 0910/98
T 0940/98
T 0431/99
T 0947/99
T 1095/99
T 0182/00
T 0426/00
T 0427/00
T 0208/01
T 0292/01
T 0326/01
T 0583/01
T 0794/01
T 1146/01
T 1217/01
T 0030/02
T 0062/02
T 0326/02
T 0370/02
T 0613/02
T 0497/03
T 0018/04
T 0359/04
T 0633/04
T 0690/04
T 0946/04
T 1169/04
T 0001/05
T 0485/05
T 0535/05
T 0987/05
T 1464/05
T 0464/06
T 0519/06
T 0560/06
T 1172/06
T 1278/06
T 1553/06
T 0007/07
T 0621/07
T 0002/09
T 0018/09
T 1039/09
T 2045/09
T 2458/09
T 0510/10
T 0682/10
T 2406/10
T 0023/11
T 0877/11
T 2517/11
T 0129/12
T 1555/12
T 1609/12
T 1822/12
T 2048/12
T 2440/12
T 2020/13
T 0205/14
T 0842/14
T 1833/14
T 0505/15
T 0834/15
T 1317/15
T 2068/15
T 2118/15
T 1409/16
T 1452/16
T 1666/16
T 1575/17
T 2114/17
T 0192/18

Source: http://www.epo.org/law-practice/case-law-appeals/recent/g920001ex1.html

Date retrieved: 17 May 2021

76 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

X A.54 EPC Novelty

X A.112 EPC Decision or opinion of the Enlarged Board of Appeal

EPO Guidelines - G Patentability

X GL G IV 7.2.1 General principles

Offical Journal of the EPO

X OJ EPO SE 1/2021, p179 - Annex 1 - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2020)

X OJ EPO SE 4/2020, p2 - I. PATENTABILITY

X OJ EPO SE 1/2020, p174 - Annex 1 - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2019)

X OJ EPO SE 1/2019, p158 - XVI. - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2018)

X OJ EPO SE 3/2018, p91 - ANNEX 2

X OJ EPO SE 3/2018, p2 - BOARDS OF APPEAL AND ENLARGED BOARD OF APPEAL CASE LAW 2017

X OJ EPO SE 5/2014, p166 - ANNEX 2

X OJ EPO SE 5/2014, p25 - PART II

Case Law Book: I Patentability

X CLR I C 3.1 General

X CLR I C 3.2.3.B Public availability of a document stored on the World Wide Web

X CLR I C 3.2.4.D Internal structure or composition of a product

X CLR I C 4.4 Taking intrinsic features into account

X CLR I C 4.5 Taking equivalents into account

X CLR I D 2 Problem and solution approach

Case Law Book: II Conditions to be met by an Application

X CLR II C 4.1 The disclosure is aimed at the skilled person

X CLR II C 6.6.9 Chemical compounds

General Case Law

X T 0406/86 (Trichlorethylene) of 2.3.1988

X T 0093/89 (Polyvinyl ester dispersion) of 15.11.1990

X T 0223/92 (HIF-Gamma/GENENTECH) of 20.7.1993

X T 0267/92 () of 4.6.1996

X T 0327/92 (Oriented film laminates of polyamides and ethylene vinyl alcohol) of 22.4.1997

X T 0472/92 (Joint Venture/SEKISUI) of 20.11.1996

X T 0952/92 (Prior use) of 17.8.1994

X T 0210/93 () of 12.7.1994

X T 0443/93 () of 22.3.1995

X T 0951/93 (Kamillendroge/ROBUGEN) of 17.9.1997

X T 0977/93 (Canine coronavirus vaccine) of 30.3.1999

X T 0097/94 (Procedural timetable) of 15.7.1997

X T 0301/94 (Green glass/AVIR) of 28.11.1996

X T 0667/94 (Antiperspirant/UNILEVER PLC ET AL) of 16.10.1997

X T 0144/95 (Dishwashing process) of 26.2.1999

X T 0277/95 (Production of erythropoietin/GENETICS INSTITUTE) of 16.4.1999

X T 0080/96 (L-carnitine) of 16.6.1999

X T 0165/96 (DÃ©lavage/CAYLA) of 30.5.2000

X T 0633/97 (Optical members/HERAEUS) of 19.7.2000

X T 1046/97 (Enantiomer/ZENECA) of 2.12.1999

X T 0226/98 (Famotidine/RICHTER GEDEON) of 7.2.2001

X T 0910/98 () of 30.10.2001

X T 0947/99 (Confectionary/UNILEVER) of 27.11.2003

X T 0426/00 () of 27.6.2003

X T 0583/01 (Pharmaceutical granulate/AKZO NOBEL N.V.) of 26.7.2005

X T 0794/01 () of 28.8.2003

X T 1146/01 () of 2.9.2004

X T 1217/01 () of 21.6.2006

X T 0030/02 (Xylanase/NOVOZYMES) of 9.10.2006

X T 0326/02 () of 11.5.2004

X T 0370/02 () of 14.12.2006

X T 0946/04 () of 2.3.2006

X T 0001/05 () of 20.4.2007

X T 0987/05 (Pentoxides/CABOT) of 14.10.2009

X T 1464/05 (Hydrogen-absorbing composition/PRYSMIAN) of 14.5.2009

X T 1172/06 (Osteogenic proteins/STRYKER) of 15.10.2008

X T 1553/06 (Public availability of documents on the World Wide Web/PHILIPS) of 12.3.2012

X T 0007/07 (Ethinylestradiol and drospirenone for use as a contraceptive/BAYER … of 7.7.2011

X T 0002/09 (Public availability of an e-mail transmitted via the Internet/PHILIPS … of 12.3.2012

X T 0018/09 (Neutrokine/HUMAN GENOME SCIENCES) of 21.10.2009

X T 1039/09 (Milk/ A2 CORPORATION LIMITED) of 5.3.2013

X T 2045/09 (Anti-ErbB3 antibody/GENENTECH) of 14.5.2014

X T 0023/11 (EUVL GLASS/ASAHI) of 13.2.2014

X T 2517/11 () of 12.10.2016

X T 0129/12 (Injector deposits control / AFTON) of 29.5.2015

X T 1822/12 () of 23.10.2014

X T 2048/12 (PU catalysts / AIR PRODUCTS) of 19.1.2016

X T 2440/12 (Fluid flow simulation/SIMCON) of 15.9.2015

X T 2020/13 () of 12.10.2017

X T 0205/14 (Ibandronate sodium, Form QQ/TEVA) of 18.6.2015

X T 0842/14 (PCR anti-foam reagents/QIAGEN) of 23.1.2019

X T 1833/14 () of 7.12.2017

X T 0505/15 (Bicarbonate solutions for dialysis/NIKKISO) of 11.7.2017

X T 0834/15 (Blocky CMC II / Procter & Gamble) of 19.4.2018

X T 2068/15 () of 25.1.2017

X T 1409/16 (Blocky CMC I / Procter & Gamble) of 19.4.2018

X T 1452/16 (Lactase preparation/DSM) of 20.9.2017